Semaglutide and Tirzepatide are two medications that have been approved by the FDA for weight loss. They are both injectable medications that work by mimicking the effects of a hormone called GLP-1, which helps to regulate blood sugar levels and reduce appetite.
Semaglutide is typically used to treat type 2 diabetes, but it has also been found to be effective for weight loss. It is administered once a week and has been shown to result in significant weight loss in clinical trials.
Tirzepatide is a newer medication that was recently approved by the FDA for weight loss. It is also administered by injection and works by targeting the hunger centers in the brain to reduce appetite. Clinical trials have shown that Tirzepatide can result in significant weight loss over a period of 12 weeks.
Naltrexone is used to reduce appetite and cravings. Semorelin is a synthetic hormone that stimulates the release of growth hormone, which can help to increase metabolism and burn fat. Lipo Acid is an antioxidant that can help to reduce inflammation and improve insulin sensitivity.